Delphinus Medical Technologies

Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Company Growth (employees)
Type
Private
HQ
Novi, US
Founded
2010
Size (employees)
57 (est)-1%
Delphinus Medical Technologies was founded in 2010 and is headquartered in Novi, US

Delphinus Medical Technologies Office Locations

Delphinus Medical Technologies has offices in Novi and Sunnyvale
Novi, US (HQ)
45525 Grand River Ave
Sunnyvale, US
100 920 Thompson Pl

Delphinus Medical Technologies Data and Metrics

Summary Metrics

Founding Date

2010

Total Funding

$58.5 m

Latest funding size

$39.5 m

Time since last funding

about 2 years

Investors

Delphinus Medical Technologies's latest funding round in September 2015 was reported to be $39.5 m. In total, Delphinus Medical Technologies has raised $58.5 m

Traffic Overview of Delphinus Medical Technologies

Delphinus Medical Technologies News and Updates

Redefining The Future of Medicine: 72 Medical Device Startups Advancing Treatment And Prevention

Medical device funding is on track to reach $3.5B in 2016, a slight increase over last year’s dollar total. Since 2012, most funding to medical device startups has occurred in the United States, with NEA leading venture capital activity and Johnson & … Continued

Delphinus Medical Technologies Company Life and Culture

You may also be interested in